Chapters

Transcript

Video

In what kinds of non-melanoma cancers does BRAF V600 appear to be a targetable oncogene? What do initial studies using BRAF V600 to guide vemurafenib and cetuximab in patients with colorectal cancer show?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Professor Jianming Xu, MD

Professor Jianming Xu, MD

Affiliated Hospital Cancer Center
Academy of Military Medical Sciences
Beijing, China